×   Holy Name (main site)   School of Nursing   HNH Fitness   Villa Marie Claire   Simulation Learning   HN Medical Partners

Physician Profile

New Jersey Medical Group

Sharyn Lewin, MD


- Gynecologic Oncology
- Oncology
- Gynecology
- Surgical Oncology

Office Location:
718 Teaneck Road Cancer Center, Teaneck, NJ 07666



Physician Profile

Medical Education

University of Kansas School of Medicine


Washington University School of Medicine - Obstetrics and Gynecology


Barnes-Jewish Hospital


Memorial Sloan Kettering Cancer Center

Awards & Recognitions

American Society of Clinical Oncology and Susan G. Komen for the Cure Clinical Award/Grant
Medical Director, Woman to Woman Program, grant funded by the Ovarian Cancer Research Foundation
American Society of Clinical Oncology Merit Award
Organon Research Award for Resident Research Excellence
Top Doctor, NY Magazine and 201 Magazine since 2015

About Me

Sharyn N. Lewin, MD, FACS, FACOG, is the Director for the Division of Gynecologic Oncology at Holy Name. She is recognized both nationally and internationally for her acumen in performing laparoscopic, robotic, and open surgery to treat complex gynecologic cancers and related malignancies of the upper abdomen and pelvic/colorectal areas. Board-certified and fellowship-trained in obstetrics/gynecology and gynecologic oncology, Dr. Lewin provides surgery and chemotherapy (including hyperthermic intraperitoneal chemotherapy [HIPEC]), thus enabling her to offer continuous care over each patient’s lifetime.

Prior to joining Holy Name, she was on the faculty of the Columbia University College of Physicians and Surgeon for five years and was the first Medical Director of the New York-Presbyterian Hospital Woman to Woman Program. She received New York-Presbyterian Hospital’s 2010 Physician of the Year Award and was honored by Gilda’s Club New York City at its 6th Annual Benefit Luncheon in 2013.

An authority on hereditary breast and ovarian cancer syndrome (which increases one’s risk for ovarian and other cancers among those who carry the BRCA breast cancer genes), Dr. Lewin has presented at national medical conventions. Her research interests include novel chemotherapeutic agents for ovarian cancer, including HIPEC and immunotherapy; quality-of-life studies; and patient outcomes following the use of integrative therapies during treatment. She is currently an Assistant Clinical Professor in the Icahn School of Medicine at Mount Sinai Hospital in New York.

As President and Executive Director of the non-profit The Lewin Fund to Fight Women’s Cancers®, Dr. Lewin is dedicated to eliminating medical, economic, and psychosocial challenges faced by women with cancer. She serves on the prestigious Gynecologic Oncology Group (GOG) Partners Investigative Council, offering key clinical trials to our patients.

Dr. Lewin credits her grandmother, a gynecologist, as the inspiration for her to pursue a career where she can make a difference in women’s lives. Dr. Lewin uses data to pinpoint the appropriate medicinal approach but relies on her personal touch to improve her patient’s quality of life.